Recent months - before the latest sell-off - have shown that the market as a whole can advance despite weakness from some of the mega tech names. But struggles for the likes of Microsoft, which still ...
Endo (NDOI) stock gains as the company is in pact with Mallinckrodt (MNKTQ) to merge in a $6.7B deal, creating a Dublin-based pharma leader. Read more here.